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Abstract: Lipid deposition can be assessed with combined intravascular 
photoacoustic/ultrasound (IVPA/US) imaging. To date, the clinical translation of IVPA/US 
imaging has been stalled by a low imaging speed and catheter complexity. In this paper, we 
demonstrate imaging of lipid targets in swine coronary arteries in vivo, at a clinically useful 
frame rate of 20 s−1. We confirmed image contrast for atherosclerotic plaque in human 
samples ex vivo. The system is on a mobile platform and provides real-time data visualization 
during acquisition. We achieved an IVPA signal-to-noise ratio of 20 dB. These data show that 
clinical translation of IVPA is possible in principle. 
© 2017 Optical Society of America 
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1. Introduction 
Cardiovascular diseases (CVDs) are the leading cause of death worldwide. In 2012, 17.5 
million people died from CVDs, representing 31% of all the global deaths. Particularly, 42% 
of these CVD deaths are due to coronary artery disease (CAD), which is most often triggered 
by the rupture of vulnerable atherosclerotic plaque and ensuing thrombosis [1, 2]. A 
vulnerable plaque is commonly described as a lipid-rich necrotic core, covered by a thin 
fibrous cap with macrophage infiltration [3]. These plaques have been implicated in worse 
short-term and long-term outcomes of coronary interventions, as they may destabilize by 
intracoronary instrumentation during the intervention, or spontaneously at a later stage. The 
identification of the vulnerable plaque requiring information on the structure and composition 
of the plaque [4], can have an important role for guiding the diagnosis and treatment of CAD. 
All commercially available intravascular imaging modalities can detect one or more of the 
defining features of a vulnerable plaque, but none provides conclusive identification [5]. 
Intravascular optical coherence tomography is well positioned for imaging fibrous cap 
thickness but has insufficient imaging depth to fully visualize the artery wall [6], and tissue 
characterization requires a high level of user expertise [7]. Intravascular ultrasound (IVUS) 
can usually see the entire vessel, but lacks resolution and soft tissue type specificity. This has 
led to the proposal of multimodal imaging strategies [8]. Optical spectroscopies are ideal for 
discriminating between tissue types, capitalizing on specific absorption features [9, 10]. IVUS 
has been combined recently with near-infrared spectroscopy (NIRS), which provides 
information about the presence of lipid-core plaque, but still is unable to measure its depth 
relative to the lumen border [11]. 
Combined intravascular photoacoustic (IVPA) and IVUS imaging is emerging as a 
promising technology for localization, characterization and quantification of coronary 
atherosclerotic plaque lipids. IVPA imaging, generating ultrasound signal by the absorption 
of a short laser pulse in the tissue, is capable of imaging the composition of the artery wall 
with an adequate imaging depth and resolution based on the optical absorption contrast 
between different tissues [12, 13]. Tissue contrast in IVPA can be chosen by tuning the 
excitation wavelength to a specific absorption band of the imaging target. We target 
atherosclerotic plaque lipid, the most prevalent marker for identifying vulnerable plaques, by 
choosing an excitation wavelength that excites a PA signal from lipids [12, 14–17], and 
ideally from atherosclerotic lipids alone [18–20]. Its co-registered IVUS image provides the 
complementary structure information of the artery wall. Although IVPA/US imaging 
potentially offers valuable information for assessment of plaque vulnerability, the slow 
imaging speed and the difficulty in design and fabrication of a miniature flexible catheter 
have presented as major challenges for translation of IVPA/US imaging into an in vivo or 
clinical application. An intensive research effort is ongoing towards the further development 
of IVPA/US imaging systems. Imaging speed is primarily limited by laser pulse rate: with the 
introduction of 500 Hz to 2 kHz repetition rate laser systems, operating at the wavelengths of 
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lipid absorption peaks near 1.2 µm or 1.7 µm, the IVPA/US lipid imaging speed has recently 
increased to about 1 frame per second (fps) [21–23]. Use of a more conventional laser 
wavelength facilitates speed but offers limited biological image contrast [24]. 
The routine for intravascular imaging is to perform a pullback while acquiring a series of 
cross-sectional images, which together form a volume scan. If using the closest relative, 
IVUS imaging, as a reference, scanning a vessel with a pullback speed of 0.5-1 mm/s and a 
frame rate of 20-50 fps is required for IVPA imaging. In this paper, we demonstrate an 
IVPA/US system with a 1.3 mm outer diameter flexible catheter, imaging coronary lipids at 
the speed of 20 fps, comparable to the speed of a conventional commercial IVUS system [25, 
26]. This frame rate is the minimum usable acquisition speed for in vivo volumetric 
(pullback) imaging, if adequate sampling is required in the presence of cardiac motion. We 
demonstrate the imaging performance in vivo in a healthy swine model with an introduced 
lipid target, and on a human atherosclerotic coronary artery sample ex-vivo. 
2. Methods and materials 
2.1 IVPA/US image acquisition and real-time visualization 
The schematic of the high-speed IVPA/US imaging system is shown in Fig. 1.The laser 
source in the system (FQ-OPO, Elforlight Ltd, Daventry, UK) is a periodically-poled LiNbO3 
OPO pumped by a pulsed Nd:YAG laser, which in turn is pumped by a CW diode. The laser 
pulse duration is approximately 10 ns, the maximum output pulse energy of the laser is 80 
µJ/pulse and the pulse repetition rate is of 5 kHz. The tuning range of the laser is from 1700 
to 1750 nm. The laser output is coupled into a multimode optical fiber with a core diameter of 
100 µm and connected to the 1.3 mm IVPA/US catheter through an optical rotary joint 
(Princetel, Hamilton, NJ, USA) and an electrical slip ring (LPT025, JINPAT Electronics, 
Shenzhen, China) inside the scanning stage. The IVPA/US catheter is based on the design we 
previously described in [27], consisting of a 100 µm diameter angle polished fiber (angled at 
34 degree, low OH, Pioneer Optics, USA), an ultrasound transducer element (40 MHz central 
frequency, 50% bandwidth, Blatek, USA), a tip assembly made from polyether ether ketone 
(PEEK), a metal torque coil and a 1.3 mm outer diameter polyethylene (PE) sheath. An 
ultrasound pulser (AVL-2-PS-P, Avtech Electrosystems Ltd, New York, NY, USA) is used to 
transmit 80 V amplitude pulses for pulse-echo imaging. A pulse/delay generator (BNC model 
575, Berkeley Nucleonics Corporation, San Rafael, CA, USA) provided timing and triggering 
signals to the laser, digitizer and the ultrasound pulser. The time delay between the PA and 
US signal is 10 µs. The received data were 43 dB amplified (AU1263, MITEQ, Long Island, 
NY, USA), band pass filtered (13–60 MHz 5th order Butterworth, custom built), digitized and 
transferred by a data acquisition card with 14 bits digitization and 400 MS/s sampling rate 
(PX14400, Signatec, New York, NY, USA) installed in a personal computer (PC). 
The data acquisition software was developed in C + + (Microsoft Visual Studio 10) to 
acquire and display the recorded data in real time. Simple data processing, including 
decimation, truncation, absolute value, normalization, and scan-conversion to Cartesian 
coordinates was applied to the acquired data before real-time data display. A video of data 
acquisition and visualization with the software interface is provided in Visualization 1. 
Rotation (313518, Maxon motor, Sachseln, Switzerland) and translation motors (143967, 
Maxon motor, Sachseln, Switzerland) were combined for helical scanning, driving the 
catheter rotation at 1200 rpm and pullback at 0.1~1 mm/s. One cross-sectional image was 
composed of 250 A-lines and the whole system is capable of IVPA/US imaging at 20 fps. All 
the devices were placed in a portable trolley for easy transportation. 
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 Fig. 1. (a) Photo of the mobile IVPA/US system. (b) Schematic of the IVPA/IVUS imaging 
system composition and illustration of the IVPA catheter components. (c) Photo of the 
pullback unit. (d) Data acquiring and display with the homemade software interface on a 
human coronary artery sample ex vivo (Visualization 1). 
2.2 Data processing 
Further signal processing on the data was performed in Matlab (R2016a; The Mathworks, 
Natick, MA, USA) offline. All received PA and US data were decimated, digitally band pass 
filtered from 10 to 60 MHz, envelope filtered, median filtered, denoised, and converted for 
display as in our previous work [12]. In the in vivo data, we noticed image wobble in the 
pullback due to variations in tip rotation speed, possibly related to cardiac motion. We applied 
a global rotational block matching correction based on the correlation of subsequent IVUS 
frames [28]. After this motion correction, we enhanced the PA signal to noise ratio (SNR) by 
averaging each A-line in a 3 × 2 (lines × frames) averaging kernel. For instance, the PA signal 
at thi  A-line and thj  frame, ,i jP , was averaged with its two adjacent A-line signals at the 
same frame 1,i jP±  and the PA signal at the same three A-lines in the next frame, 1, 1i jP± + . 
Furthermore, in vivo imaging is performed through the PE sheath, which attenuates PA 
signal and introduces strong reflection artifacts. The reflection artifacts are highly correlated 
throughout the pullback recording. The reference reflection artifact PA signal was constructed 
from the PA images without the lipid target and was used to cancel the artifacts in images 
with the lipid target. 
2.3 Human coronary artery sample preparation 
One artery sample (LAD, 48 year old male) was collected at autopsy from the Department of 
Pathology of Erasmus Medical Center (MC), after obtaining consent from the relatives. The 
research protocol was sanctioned by the Medical Ethics Committee of Erasmus MC (MEC-
2007-081). The coronary artery was frozen within 2h after autopsy and stored at −80° until 
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analysis a few months later. Prior to analysis, the artery was thawed and measured within 
several hours. In the measurement, metal needles were used to fix the artery specimen inside 
a small container filled with D2O-saline and register the pullback locations. Figure 2(a) shows 
a photo of the prepared artery sample for the measurement. The IVPA/US measurement was 
performed at room temperature at the wavelength of 1720 nm. To maximize the PA SNR, the 
PE sheath was removed during the measurement. A pullback data set containing 500 frames 
was acquired at a pullback speed of 0.1mm/s. All the IVPA/IVUS images were non-averaged. 
After the measurement, we cut the part of the artery sample imaged, embedded in optimal 
cutting temperature compound (Tissue-Tek, Sakura Finetek Europe B.V., Alphen a/d Rijn, 
The Netherlands), and stored it at −80°C until further processing. For histology, we sliced the 
whole frozen artery block into a series of 10 µm thick sections. Oil Red O (ORO) staining 
was applied to all these sections to detect lipids. 
2.4 In vivo IVPA/US imaging in swine coronary lipid model 
To further test the imaging system, an in vivo IVPA/US experiment was performed on a 
healthy farmbred (Yorkshire-landrace) swine. The animal was sedated using Zoletil 100 
(Virbac Nederland BV, Barneveld, The Netherlands), Sedazine (AST Farma BV, Oudewater, 
The Netherlands) and Atropine (Pharmachemie BV, Haarlem, The Netherlands), and 
anesthesia was maintained using pentobarbital (10-15 mg/kg/hr) while connected to a 
ventilator as described before [29]. The protocol was approved by the Erasmus MC Animal 
Ethics committee and was performed in accordance with the Guide for Care and Use of 
Laboratory Animals [30]. Following anesthesia and a surgical cut-down, a sheath was 
introduced into the carotid artery. Then a guiding catheter was advanced to the right coronary 
artery (RCA) for stent placement and intravascular imaging. Under guidance of angiography 
a small piece of pork lard was delivered into the coronary artery to mimic the plaque lesion as 
described by Lovrak et al. [31]. The pork lard (lipid target) was fixed at its two ends with two 
small, modified, double-layered stents on the balloon catheter (Pantera Pro 4.0/15; Biotronik 
SE & Co. KG, Berlin, Germany). Figure 3(a) shows the photo of the lipid rich material with 
stents mounted on the balloon catheter. To prevent the two stents from being pushed apart 
while inflating the balloon, we connected them with the black surgical wires. 
Then, the IVPA/US catheter was advanced into the RCA with a GuideLiner catheter (6F, 
Vascular Solutions, Minneapolis, MN, USA). The metal stents and the catheter were radio-
opaque, thus, the pullback locations could be easily tracked by X-ray imaging [Fig. 3(b)]. In 
this way, IVPA/US pullback recording was arranged to cover the lipid target region (the 
region in between the two stents) at a speed of 0.5mm/s. Each pullback recording contains at 
least 200 frames. The in vivo experiment was also performed at 1720 nm, but unlike the ex 
vivo experiment, it imaged through the PE sheath. During the experiment, we continuously 
flushed the artery with heavy water-based saline. After the experiment, we sacrificed the pig, 
cut the artery open and confirmed the presence of the lipid target inside the RCA. 
3. Results 
3.1 Ex vivo IVPA/US imaging of human coronary artery 
We imaged a human atherosclerotic plaque specimen, obtained from autopsy. Figure 2 shows 
the combined IVUS/IVPA data. An atherosclerotic lesion with a variable amount of 
intraplaque lipid, photographed in its holder in Fig. 2(a), is visualized by IVPA/US. The lipid 
content increases in the pullback direction, from left to right in Fig. 2(b), appearing from 3 
o’clock to 7 o’clock in the 3D reconstruction of the pullback data. Histology validations by 
Oil Red O lipid stain are shown at two pullback locations, indicated with yellow and blue 
contours in Fig. 2(b). In the combined IVPA/US images [Fig. 2(c) and 2(e)], the IVPA signal 
can be clearly appreciated at the corresponding thickened intima region within the artery wall 
(from 2 o’clock to 7 o’clock). This suggests the presence of a lipid-rich plaque, an 
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observation that is confirmed by comparison with the histology. The proximal location [Figs. 
2(c) and 2(d)] shows a bright IVPA signal corresponding to a dense lipid-laden intima. The 
more distal location [Figs. 2(e) and 2(f)] exhibits a markedly lower IVPA signal, and a less 
extensive lipid infiltration on histology. 
IVPA achieved full visualization of the lipid-rich lesion throughout the depth of the 
plaque. The signal-to-noise ratio (SNR) of the PA signal in the plaque region in the image is 
approximately 20 dB without any averaging, validating the capability of plaque visualization 
with enough imaging depth by IVPA imaging at 1.7 µm in coronary artery. 
 
Fig. 2. IVPA/US cross-sectional image of an atherosclerotic human coronary artery. (a) Photo 
of the human LAD sample fixed inside a holder. (b) 3D reconstruction of the pullback 
IVPA/US images. (c) Merged IVPA/US image of the plaque at locations with large plaque 
volume (the location with a yellow contour) and (e) with small plaque volume (the location 
with a blue contour). (d) and (f) The ORO histology staining at the imaging plane 
corresponding to images of (c) and (e). The dynamic range is 35 dB in IVUS image and 20 dB 
in IVPA image. No averaging was applied to IVUS or IVPA data. 
3.2 In vivo IVPA/US imaging of swine coronary artery 
In vivo IVPA/US imaging of a swine coronary artery with an artificial plaque is shown in Fig. 
3. A lipid target was introduced into the coronary artery of a healthy animal by attaching a 
piece of pork fat to a pair of coronary stents and deploying them to attach it to the vessel wall 
[Fig. 3(a)]. Stents were introduced on a balloon under angiography guidance [Fig. 3(b)]. We 
acquired a pullback data set using the experimental IVPA/US catheter and system. A 
longitudinal section of the pullback IVPA/US data containing the lipid target is shown in Fig. 
3(c), along with cross-sectional images at two selected pullback locations; one inside the lipid 
region (yellow line) and the other one outside (blue line). The lipid target can also be seen in 
the IVUS images as an intraluminal, echogenic object, and this was used to delineate the 
target by the dotted contour in Figs. 3(c) and 3(d). In the IVPA/US images of the lipid target 
[Figs. 3(d)-3(f)], a bright PA signal at 6 o’clock to 9 o’clock inside the lumen, generated from 
the lipid, is clearly observed with an SNR≈18 dB (marked with a yellow contour). As a 
reference, the characteristic PA signal disappears in absence of the lipid target; remaining 
signal is concentric with the catheter and is attributed to artifacts arising from signal 
                                                                                Vol. 8, No. 2 | 1 Feb 2017 | BIOMEDICAL OPTICS EXPRESS 949 
generation in the catheter sheath. The entire IVPA/US pullback data display (300 frames data) 
video is shown in Visualization 2. 
 
Fig. 3. In vivo IVPA/US imaging result on a swine model. (a) Stents with lipid target mounted 
on a balloon catheter. (b) X-ray imaging of the pullback location. The stents were inside the 
yellow boxes and the lipid target located in between the two stents. (c) Longitudinal view of 
the pullback merged IVPA/US data at an angle intersecting with the lipid object [indicated 
with a purple line in (d)]. (d,e,f) Cross-sectional IVUS, IVPA, and merged IVPA/US image at 
the pullback location indicated with a yellow line in (c). (g,h,i) Cross-sectional IVUS, IVPA 
and merged IVPA/US image at the pullback location indicated with a blue line in (c).The 
dynamic range is 32 dB for IVUS images and 18 dB for IVPA images; scale bar in (f) applies 
to all of (d)-(i). The complete pullback data set is available as Visualization 2. 
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By IVUS, the lipid target appears larger than by IVPA: the IVPA does not detect the 
entire lipid inclusion. We attribute this to a combination of catheter limitations and image 
processing: During imaging, the target did not align perfectly with the artery wall, as 
expected, and as a result was very close to the catheter [Fig. 3(d)]. As described in our 
previous work [27], an IVPA catheter with a longitudinal beam offset has a low sensitivity to 
targets that are in close proximity to the transducer due to small optical/acoustic beam 
overlap. Secondly, imaging artifacts originating from light absorption in the catheter sheath 
overlapped with the lipid signal. Additional data processing to suppress the artifacts partially 
suppressed the lipid signal, while some residual artifacts remained, indicated with white 
arrows in Fig. 3(e). These factors also contribute to more readily apparent motion in the IVUS 
data. 
4. Discussion 
In this work, we demonstrated in vivo IVPA/US imaging based on a system using a 5 kHz 
laser with a flexible 1.3 mm catheter, capable of volumetric lipid detection in coronary 
arteries at 20 frames per second. We validated the imaging system performance on a human 
coronary artery ex vivo and on a swine coronary artery in vivo. It is the first in vivo IVPA/US 
imaging in a coronary artery reported to date, acquiring images of coronary lipid in this 
highly mobile, challenging environment. Our IVPA/US imaging system significantly 
increased the imaging speed from 1 fps (the fastest imaging speed reported so far for a lipid-
imaging IVPA system) to 20 fps [21–23, 31]. The operating parameters of our 
implementation of this technology match those desired of a clinical imaging system in terms 
of acquisition speed, operating wavelength, and scan method. The catheter proved to be 
sufficiently robust for in vivo imaging. Further miniaturization of the device is possible and 
has been demonstrated [31, 32]; the outer diameter could be reduced to < 1 mm with a smaller 
torque coil and outer sheath. 
The IVPA/US system performs acquisition and real-time display of dual-modality data, 
meaning the data is visualized during imaging at the same rate that it is acquired. This is a key 
step for usability of IVPA in real-world settings. The image optimizations we performed off-
line in the in vivo experiments do not require user intervention and could be incorporated 
straightforwardly in the real-time visualization (inducing a one-frame display delay). 
The laser source in our system has a high repetition rate but moderate pulse energy. 
Partially due to ineffective coupling and scattering at the catheter tip, the optical exposure is 
less than 0.4 J/cm2 at 1.7 µm, which is below the 1 J/cm2 threshold specified by the ANSI 
laser safety standard [22]. Despite using a pulse energy which is one order of magnitude 
lower than that used previously in IVPA/US systems working at 1.7 µm, the PA SNR 
achieved in our imaging system was 20 dB, comparable to earlier reports [22, 23]. We used 
pork lard as a lipid target for in vivo imaging, which has a different lipid composition, and 
thus a slightly different absorption spectrum, compared to lipid-rich plaque [20]. However, at 
the selected wavelength (1720 nm), both pork lard and plaque generate strong PA signals. An 
alternative synthetic plaque is being developed, containing the same types of lipids as in 
plaques to better mimic the plaque lipid signature [33]. This material can be introduced in a 
similar manner as we did in the present study. 
Some challenges clearly remain for the clinical translation of IVPA/US imaging, 
particularly in the catheter design. In a typical miniature non-collinear IVPA catheter, the 
offset between the acoustic and optical beams, longitudinally or laterally, leads to a low PA 
SNR when targets are close to the transducer [27]. Collinear catheter designs do not face this 
problem, but are more prone to image artefacts resulting from near-field optical absorption 
[34]. Another difficulty in catheter design is the sheath material, which needs to be 
transparent for both ultrasound and light (at 1.7 µm). The polyethylene (PE) material in our 
current catheter sheath is abundant in C-H bonds as lipids, which makes it a strong absorber 
at wavelengths providing lipid-specific contrast. A PE sheath absorbs almost half of the PA 
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excitation energy, leading to a reduction in PA SNR and strong reflection artefacts due to 
echoes of the sheath-generated signal in IVPA image (Fig. 4). Especially, during the in vivo 
swine experiment, the artifact from PE sheath appears close to the lipid target, making the PA 
signal from lipid target a mixture with sheath artifact, which is difficult to completely cancel 
without losing PA signal originating from tissue. A direct comparison between images with 
and without sheath shows a similar reduction in PA energy [24]. 
Attenuation and artifacts affect the quality of in vivo IVPA images compared to the ex 
vivo IVPA results, collected without sheath. Fluorinated polymers, such as PTFE are an 
interesting alternative, but tend to have suboptimal mechanical and acoustic properties in their 
crystalline forms. Fabrication of amorphous fluorinated polymer, such as perfluoro-3-butenyl-
vinyl ether (CytopTM), which is flexible and has a 95% transmittance of the light at 1.7 µm 
[35], in tube form would make these promising materials available for evaluation as catheter 
sheaths. 
 
Fig. 4. Merged cross-sectional IVPA/US image of the in vivo result on a swine coronary artery 
with artificial plaque lesion. White arrow indicates the PE sheath artifact, yellow arrow 
indicates the black surgical wire and blue arrow indicates the mixture of lipid signal and PE 
sheath artifact. 
Fast and stable laser systems are also essential for translation of IVPA/US imaging to the 
clinical setting. We need to strike a balance between pulse rate (for speed), pulse energy 
(SNR), and overall power delivered to the vessel (safety). As 1.7 µm radiation is strongly 
absorbed by water, it is considered an eye-safe wavelength, which reduces concerns for user 
safety. We have not seen evidence of laser tissue damage in our human or swine samples, 
upon deposition of 150 mW of light in the artery. Nevertheless, optically and acoustically 
efficient designs allow for minimization of the applied laser power while preserving SNR. In 
recent work [36], we found that 80% of PA power from lipid-rich plaque is at frequencies 
below 8 MHz, and the PA SNR can be increased up to 20 dB by covering the frequency band 
below 8 MHz. We experienced >50% optical loss due to fiber coupling and scattering in the 
tip optics, which is clearly suboptimal. Improved catheter design and functionality may 
enable IVPA lipid imaging with lower laser pulse energy and output power. Such moderate-
output power lasers may prove to be more robust, user-friendly and affordable than the 
complex OPO system we currently use. 
In the present series of experiments, we have chosen to clear blood from the artery for 
optimizing PA SNR. It is possible to image lipids through blood at 1.7 µm by IVPA imaging 
[16] due to the relatively small scattering coefficient at infrared wavelengths [37]. H2O 
absorption is significant, both in blood and in saline flush, which is why we use D2O-saline 
for flushing. Heavy water is non-toxic but expensive, which may present as a limitation going 
forward. 
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In summary, we demonstrated volumetric in vivo IVPA/US of lipid in the coronary 
circulation of a healthy swine. We built an imaging system with a miniature flexible catheter, 
allowing to image lipid-rich plaque lesions at 20 fps. The system produces good IVPA/US 
images of lipids with a PA SNR of about 20 dB at the an imaging frame rate that is 
compatible with comprehensive pullback imaging of coronary plaques. 
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